Bionano Genomics, Inc.
BNGO
Positions held
Your positionsBNGO isn't in your positions.
Add it to see shares, cost, and P&L here.
Fundamentals
| Market cap | $17.19M | Enterprise value | $13.98M | Trailing P/E | — | Forward P/E | -1.51 |
| PEG | — | Price / book | 0.54 | Beta | 1.66 | Dividend yield | 0.00% |
| Revenue growth | 21.4% | Earnings growth | — | Gross margin | 47.5% | Operating margin | -88.3% |
| Profit margin | -106.6% | ROE | -83.6% | ROA | -32.6% | Debt / equity | 0.21 |
| Current ratio | 2.48 | Free cash flow | $2.35M | Analyst recommendation | none | Mean target | $5.00 |
| 52w high | $2.23 | 52w low | $1.00 |
Quarterly
| 2026-Q2 | 2026-Q1 | 2025-Q4 | 2025-Q3 | 2025-Q2 | 2025-Q1 | |
|---|---|---|---|---|---|---|
| Revenue | $8.2M | $6.7M | $8.0M | $7.4M | $6.7M | — |
| Op margin | -88.3% | -118.1% | -107.4% | -115.9% | -115.8% | — |
| Net income | -$7.4M | -$8.3M | -$7.9M | -$8.5M | -$6.9M | — |
| Gross margin | 52.8% | 48.6% | 42.7% | 45.7% | 51.6% | — |
| Gross profit | $4.3M | $3.3M | $3.4M | $3.4M | $3.5M | — |
| Operating income | -$7.2M | -$7.9M | -$8.5M | -$8.5M | -$7.8M | — |
- Revenue +22% vs prior quarter ($8.2M vs $6.7M).
- Gross margin 52.8% (was 48.6% prior quarter).
- Operating margin expanded to -88.3%.
Yearly (6y)
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Revenue | $28.5M | $30.8M | $36.1M | $27.8M | — |
| Op margin | -116.9% | -247.8% | -380.0% | -473.7% | — |
| Net income | -$26.4M | -$112M | -$232M | -$133M | — |
| Gross margin | 46.3% | 1.2% | 26.5% | 21.4% | — |
| Gross profit | $13.2M | $0.4M | $9.6M | $5.9M | — |
| Operating income | -$33.3M | -$76.3M | -$137M | -$132M | — |
No flags
• No distress or material-risk keywords in recent headlines (keyword scan only — not a guarantee).
News
2026-08-24 · Bionano to Participate in the H.C. Wainwright 28th Annual Global Investment Conference
2026-08-17 · Bionano Genomics (BNGO) Q2 2026 Earnings Call Transcript
2026-08-11 · Bionano Genomics Inc (BNGO) (Q2 2026) Earnings Call Highlights: Record Flow Cell Sales and ...
2026-08-11 · Bionano Genomics, Inc. Q2 2026 Earnings Call Summary
2026-08-10 · Bionano Reports Second Quarter 2026 Results and Provides a Business Update
2026-08-07 · Earnings To Watch: Bionano Genomics Inc (BNGO) Q2 2026 -- GF Value Sees 27% Upside
2026-07-27 · Bionano to Report Second Quarter 2026 Financial Results and Host a Conference Call Webcast on August 10, 2026
Price (daily)
Full chart · RSI · MACD · patterns